United Therapeutics (UTHR) is a strong value investing candidate with low P/E, zero debt, high profitability, and excellent financial health, offering a solid margin of safety.
Nvidia warned that a new U.S. bill could hurt its global edge by restricting AI chip exports, while growing pressure pushes tech firms like OpenAI to seek alternatives.
Sen. Elizabeth Warren accused President Donald Trump of lying about lowering costs while his tariffs raise prices and his family's WLFI crypto venture reportedly boosted their wealth by $5 billion.
Outperforming the broader indexes and these AI chip peers, Broadcom stock is now up more than +40% in 2025, and investors may be wondering if they should buy into the post-earnings spike in AVGO.
Cathie Wood said artificial intelligence and other breakthrough technologies will spark a massive productivity boom that could push U.S. inflation to zero while reshaping economic growth.
The expectation is for Q3 earnings to increase by +5.1% from the same period last year on +6% higher revenues. This would follow earnings growth rates of +12.4% and +12.3% in 2025 Q2 and Q1, respectively.
